AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionD'Orazio & Associates, Inc.
Latest Disclosed Ownership5,483 shares
Latest Disclosed Value $ 1,192,419
D'Orazio & Associates, Inc. reports 1.98% decrease in ownership of 4AB / AbbVie Inc.

On May 7, 2026 - D'Orazio & Associates, Inc. filed a 13F-HR form disclosing ownership of 5,483 shares of AbbVie Inc. (BG:4AB) valued at $1,192,419 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 5,594 shares of AbbVie Inc.. This represents a change in shares of -1.98% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBVIE COM 00287Y109 5,483 -111 -1.98 1,192 -6.73 0.1544
2026-02-04 2025-12-31 13F ABBVIE COM 00287Y109 5,594 526 10.38 1,278 8.95 0.1336
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 5,068 346 7.33 1,173 33.90 0.1550
2025-08-08 2025-06-30 13F ABBVIE COM 00287Y109 4,722 -182 -3.71 877 -14.70 0.1235
2025-04-17 2025-03-31 13F ABBVIE COM 00287Y109 4,904 247 5.30 1,027 24.18 0.1558
2025-01-28 2024-12-31 13F ABBVIE COM 00287Y109 4,657 24 0.52 828 -9.52 0.1218
2024-11-05 2024-09-30 13F ABBVIE COM 00287Y109 4,633 42 0.91 915 16.14 0.1296
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 4,591 2 0.04 787 -5.75 0.1208
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 4,589 355 8.38 836 27.29 0.1347
2024-02-08 2023-12-31 13F ABBVIE COM 00287Y109 4,234 -142 -3.24 656 0.61 0.1175
2023-10-11 2023-09-30 13F ABBVIE COM 00287Y109 4,376 948 27.65 652 41.43 0.1464
2023-08-04 2023-06-30 13F ABBVIE COM 00287Y109 3,428 -473 -12.13 462 -25.76 0.1078
2023-04-24 2023-03-31 13F ABBVIE COM 00287Y109 3,901 -69 -1.74 622 -3.12 0.1612
2023-01-26 2022-12-31 13F ABBVIE COM 00287Y109 3,970 152 3.98 642 25.20 0.1520
2022-10-14 2022-09-30 13F ABBVIE COM 00287Y109 3,818 1,227 47.36 512 28.97 0.1497
2022-08-15 2022-06-30 13F ABBVIE COM 00287Y109 2,591 -63 -2.37 397 -7.67 0.1055
2022-05-02 2022-03-31 13F ABBVIE COM 00287Y109 2,654 504 23.44 430 47.77 0.1037
2022-02-07 2021-12-31 13F ABBVIE COM 00287Y109 2,150 58 2.77 291 28.76 0.0672
2021-11-10 2021-09-30 13F ABBVIE COM 00287Y109 2,092 187 9.82 226 5.12 0.0550
2021-08-04 2021-06-30 13F ABBVIE COM 00287Y109 1,905 -15 -0.78 215 3.37 0.0554
2021-05-05 2021-03-31 13F ABBVIE COM 00287Y109 1,920 24 1.27 208 2.46 0.0581
2021-02-05 2020-12-31 13F ABBVIE COM 00287Y109 1,896 -195 -9.33 203 10.93 0.0656
2020-10-19 2020-09-30 13F ABBVIE COM 00287Y109 2,091 199 10.52 183 -1.61 0.0740
2020-07-22 2020-06-30 13F ABBVIE COM 00287Y109 1,892 11 0.58 186 30.07 0.0809
2020-04-28 2020-03-31 13F ABBVIE COM 00287Y109 1,881 4 0.21 143 -13.86 0.0700
2020-01-22 2019-12-31 13F ABBVIE COM 00287Y109 1,877 5 0.27 166 16.90 0.0491
2019-11-01 2019-09-30 13F ABBVIE COM 00287Y109 1,872 372 24.80 142 30.28 0.0456
2019-08-05 2019-06-30 13F ABBVIE COM 00287Y109 1,500 -22 -1.45 109 -11.38 0.0314
2019-05-01 2019-03-31 13F ABBVIE COM 00287Y109 1,522 1,522 123 0.0364
2019-01-23 2018-12-31 13F ABBVIE COM 00287Y109 0 -198 -100.00 0 -100.00
2018-11-13 2018-09-30 13F ABBVIE COM 00287Y109 198 2 1.02 19 5.56 0.0069
2018-08-09 2018-06-30 13F ABBVIE COM 00287Y109 196 196 18 0.0069
2016-02-11 2015-12-31 13F AbbVie COM 00287Y109 0 -38 -100.00 0 -100.00
2015-10-28 2015-09-30 13F AbbVie COM 00287Y109 38 38 2 0.0010
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.